Seungsoo Rho
Overview
Explore the profile of Seungsoo Rho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim M, Kim Y, Rho S, Ha A
BMJ Open
. 2025 Feb;
15(2):e085303.
PMID: 40010813
Introduction: The primary therapeutic approach to glaucoma involves the long-term use of intraocular pressure (IOP)-lowering eyedrops. However, the prevalent use of benzalkonium chloride (BAK) as a preservative in glaucoma eyedrops...
2.
Park H, Lee E, Han J, Rho S, Shin J, Park D
Eye (Lond)
. 2025 Feb;
PMID: 39979615
Purpose: This study evaluated the short-term efficacy and safety of the A-stream Glaucoma Shunt (A-stream; MICROT Inc., Republic of Korea) in patients who completed 6 months of follow-up after implantation....
3.
Kim J, Rhim W, Lee S, Park J, Song D, Cha S, et al.
ACS Nano
. 2024 Dec;
18(50):33937-33952.
PMID: 39648484
Extracellular vesicles (EVs) possess the characteristics of their parent cells, based on which various studies have actively investigated treatments for diseases using mesenchymal stem cell-derived EVs due to their regenerative...
4.
Lee S, Park J, Rhim W, Lee E, Lee S, Kim J, et al.
Nano Converg
. 2024 Oct;
11(1):43.
PMID: 39460807
With the severity of chronic kidney disease worldwide, strategies to recover renal function via tissue regeneration provide alternatives to kidney replacement therapy. To exclude side effects from direct cell transplantation,...
5.
Kim J, Lee S, Cha S, Park J, Song D, Lee S, et al.
Int J Mol Sci
. 2024 May;
25(10).
PMID: 38791285
Extracellular vesicles (EVs) have been found to have the characteristics of their parent cells. Based on the characteristics of these EVs, various studies on disease treatment using mesenchymal stem cell...
6.
Kim M, Kim J, Rhim W, Cimaglia G, Want A, Morgan J, et al.
Acta Neuropathol Commun
. 2024 Apr;
12(1):65.
PMID: 38649962
The progressive and irreversible degeneration of retinal ganglion cells (RGCs) and their axons is the major characteristic of glaucoma, a leading cause of irreversible blindness worldwide. Nicotinamide adenine dinucleotide (NAD)...
7.
Kim M, Rho S, Lim S
Ophthalmol Ther
. 2023 Oct;
12(6):3281-3294.
PMID: 37792244
Introduction: This study reports the long-term intraocular pressure (IOP)-lowering efficacy and safety of a single trabecular microbypass stent (iStent; Glaukos Corp., San Clemente, CA, USA) for medically controlled open-angle glaucoma...
8.
Kim Y, Kim M, Kim D, Rho S
J Clin Med
. 2023 Jul;
12(13).
PMID: 37445328
This case report describes the successful use of a XEN gel stent for controlling intraocular pressure (IOP) in a patient who had previously undergone scleral encircling for rhegmatogenous retinal detachment....
9.
10.
Kim K, Lee C, Shin J, Kim Y, Rho S
Sci Rep
. 2023 Apr;
13(1):5700.
PMID: 37029145
This multicenter (four institutions), randomized, investigator-masked, parallel-group clinical trial evaluated and compared the efficacy and safety of preservative-free and preserved brimonidine tartrate 0.15% in open-angle glaucoma and ocular hypertension. Sixty...